These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7891502)

  • 21. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
    Khan YA; Kashiwabuchi RT; Martins SA; Castro-Combs JM; Kalyani S; Stanley P; Flikier D; Behrens A
    Ophthalmology; 2011 Feb; 118(2):324-31. PubMed ID: 20884060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acanthamoeba keratitis: first recorded case from a Palestinian patient with trachoma.
    Pyott A; Hay J; Seal D
    Br J Ophthalmol; 1996 Sep; 80(9):849. PubMed ID: 8942385
    [No Abstract]   [Full Text] [Related]  

  • 23. Painless Acanthamoeba Keratitis with Normal Vision.
    Kwok PW; Kam KW; Jhanji V; Young AL
    Optom Vis Sci; 2017 Mar; 94(3):432-435. PubMed ID: 27870779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyhexamethylene biguanide treatment for Acanthamoeba keratitis.
    Sullivan L
    Aust N Z J Ophthalmol; 1998 Feb; 26(1):99. PubMed ID: 9524039
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of Acanthamoeba keratitis.
    Seal D
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):205-8. PubMed ID: 15482114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acanthamoeba keratitis related to cosmetic contact lenses.
    Lee JS; Hahn TW; Choi SH; Yu HS; Lee JE
    Clin Exp Ophthalmol; 2007 Nov; 35(8):775-7. PubMed ID: 17997788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].
    Vaquero Ruano M; Encinas Martín JL; Ramón Y Cajal S; Cajigal Morales C
    Arch Soc Esp Oftalmol; 2002 May; 77(5):279-81. PubMed ID: 12023748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage.
    Demirci G; Ay GM; Karabas LV; Altintas O; Tamer GS; Cağlar Y
    Cornea; 2006 Apr; 25(3):356-8. PubMed ID: 16633040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral radial keratoneuritis resulting from acanthamoeba keratitis.
    Lee PY; Lin CC; Chiu LY; Lee PY
    Kaohsiung J Med Sci; 2022 Jan; 38(1):79-80. PubMed ID: 34528392
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
    Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L
    Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acanthamoeba keratitis during orthokeratology.
    Wilhelmus KR
    Cornea; 2005 Oct; 24(7):864-6. PubMed ID: 16160506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with a derivative of propamidine for keratitis in a user of soft lenses].
    Martín Sánchez AM; de la Cuesta López A; de Miguel Martínez I; Llona Colino G
    Med Clin (Barc); 1992 Oct; 99(14):558-9. PubMed ID: 1434995
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
    Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
    Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Papa V; Rama P; Radford C; Minassian DC; Dart JKG
    Br J Ophthalmol; 2020 Apr; 104(4):575-581. PubMed ID: 31401556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acanthamoeba griffini. Molecular characterization of a new corneal pathogen.
    Ledee DR; Hay J; Byers TJ; Seal DV; Kirkness CM
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):544-50. PubMed ID: 8595954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
    Vasseneix C; Gargala G; François A; Hellot MF; Duclos C; Muraine M; Benichou J; Ballet JJ; Brasseur G; Favennec L
    Cornea; 2006 Jun; 25(5):597-602. PubMed ID: 16783150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent cluster of childhood microbial keratitis due to orthokeratology.
    Tran T; Samarawickrama C; Petsoglou C; Watson S
    Clin Exp Ophthalmol; 2014 Nov; 42(8):793-4. PubMed ID: 24533751
    [No Abstract]   [Full Text] [Related]  

  • 40. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.
    Bacon AS; Frazer DG; Dart JK; Matheson M; Ficker LA; Wright P
    Eye (Lond); 1993; 7 ( Pt 6)():719-25. PubMed ID: 8119418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.